Sign in   |   Register
HOME MARKET NEWS CENTRE ECONOMY RESEARCH MUTUAL FUNDS FINANCIAL PLANNING INSURANCE BUDGET ABOUT US F&O IPO Commodities Stock-Screener Get NAV Snapshot Portfolio Dividends News Interviews Charts 23 March, 2025 14:01 IST Get Quote Snapshot Charts Financials Research News iWealth Tracker Newsletter Tax Corner Financial Health Check Expert Speak Feedback Follow @myirisdotcom

Supriya Lifescience makes stellar debut; lists at 55% premium Source: IRIS | 28 Dec, 2021, 02.02PM Rating: NAN / 5 stars. Comments  |  Post Comment Notice: Undefined variable: fileR in /me/beta.myiris.com/htdocs/newsCentre/bin/addLinksNew.php on line 17 Notice: Undefined variable: fileR in /me/beta.myiris.com/htdocs/newsCentre/bin/addLinksNew.php on line 142 Supriya Lifescience, a pharma API manufacturer, made a stellar debut with 55% gains, listing at Rs 425/share against IPO price of Rs 274, amidst positive market sentiments. It has a niche product portfolio of 38 APIs with focus primarily on diverse therapeutic areas. It has consistently been India’s largest exporter of certain niche products with well-balanced presence between regulated and semi/non-regulated markets. Commenting on the IPO, Sneha Poddar, AVP Retail Research, Motilal Oswal Financial Services said, "We like Supriya for its niche product portfolio, backward integrated business model and robust financials. It is well placed to tap opportunity in the pharma API market given its strong pipeline focused on further diversification." Disclaimer: IRIS has taken due care and caution in compilation of data for its website. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.  Post Comment Name Email Comment Security Code type    Notice: Undefined variable: captchacode in /me/beta.myiris.com/htdocs/newsCentre/comments.php on line 183 into this box

Related Articles

Notice: Constant DOC_ROOT_FOR_HTML_FILES already defined in /me/beta.myiris.com/htdocs/newsCentre/rightSideTabs.php on line 1 Most Read Expert Speak 22-09-16 Sensex surges over 300 points as US Federal Reserve holds rate 22-09-16 Sensex gains 281 points; Nifty trades at 8,862-level 22-09-16 Rupee appreciates 18 paise against dollar in early trade 22-09-16 Edelweiss Group to acquire Ambit Alpha Fund more... more...

Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise © All rights reserved. IRIS Business Services Limited A Disclaimer

Warning: fopen(/me/beta.myiris.com/htdocs/newsCentre/news_web_count.txt): failed to open stream: Permission denied in /me/beta.myiris.com/htdocs/newsCentre/storyShow.php on line 566

Warning: fwrite() expects parameter 1 to be resource, boolean given in /me/beta.myiris.com/htdocs/newsCentre/storyShow.php on line 567

Warning: fclose() expects parameter 1 to be resource, boolean given in /me/beta.myiris.com/htdocs/newsCentre/storyShow.php on line 568

Notice: Undefined index: key in /me/beta.myiris.com/htdocs/newsCentre/storyShow.php on line 571